Bellevue Life Sciences Acquisition Ownership | Who Owns Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition Ownership Summary
Bellevue Life Sciences Acquisition is owned by 0.35% institutional investors, 58.65% insiders, and 41.00% retail investors. Tower research capital llc (trc) is the largest institutional shareholder, holding 0% of BLAC shares.
BLAC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bellevue Life Sciences Acquisition | 0.35% | 58.65% | 41.00% |
| Sector | Financial Services Stocks | 36.95% | 15.48% | 47.58% |
| Industry | Shell Companies Stocks | 236.77% | 19.11% | -155.88% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tower research capital llc (trc) | - | - | - |
| Ubs group | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tower research capital llc (trc) | - | - | - |
| Ubs group | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | - | - | -5.00 |
| Tower research capital llc (trc) | - | - | -105.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tower research capital llc (trc) | - | - | -105.00 |
| Ubs group | - | - | -5.00 |
Sold Out
| Holder | Change |
|---|---|
| Ubs group | -5.00 |
| Tower research capital llc (trc) | -105.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 3 | -76.92% | 14,270 | -99.08% | - | 0.02% | - | -100.00% | 2 | -50.00% |
| Sep 30, 2024 | 13 | -13.33% | 1,556,780 | -3.70% | 38 | 2.41% | 4 | -20.00% | 4 | -20.00% |
| Jun 30, 2024 | 15 | -37.50% | 1,616,626 | -49.18% | 40 | 1.25% | 5 | -50.00% | 5 | 150.00% |
| Mar 31, 2024 | 24 | - | 3,181,220 | 7.12% | 56 | 3.52% | 10 | -9.09% | 2 | -71.43% |
| Dec 31, 2023 | 24 | -33.33% | 2,969,727 | -45.68% | 40 | 1.10% | 11 | -15.38% | 7 | 16.67% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | - | Buy | $4.95M |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | Buy | $4.95M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2023 Q1 | 2 | - |
BLAC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools